<DOC>
	<DOCNO>NCT02014922</DOCNO>
	<brief_summary>Dry eye common condition often affect woman elderly , cause eye produce enough tear , tear evaporate quickly . Although n't simple cure dry eye , numerous product market attempt help relieve discomfort cause condition . Some product include artificial tear , omega-3 supplement , and/or anti-inflammatory medication . The purpose study evaluate performance combination TheraTears® product , compare product ( ) use .</brief_summary>
	<brief_title>A Study Determine Relief Dry Eye Symptoms With Use TheraTears® Products ( DUNLIN )</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>1 . Is 18 65 year age full legal capacity volunteer ; 2 . Has read sign information consent letter ; 3 . Is willing able follow instruction maintain appointment schedule ; 4 . Exhibits symptom dry eye least 3 month ; 5 . Has OSDI score ≥ 23 ; 6 . Is currently nonomega 3 dry eye treatment regimen , minimum consist instill artificial tear least day past 3 month ; 7 . Has average noninvasive tear breakup time ≤ 5.00 second least one eye . 1 . Is participate concurrent clinical research study ; 2 . Has know active* ocular disease and/or infection and/or allergy ; * For purpose study , active ocular disease define infection inflammation require therapeutic treatment . Lid abnormality ( blepharitis , meibomian gland dysfunction , papilla ) , corneal conjunctival stain dry eye typical finding consider active ocular disease . Neovascularization corneal scar result previous hypoxia , infection inflammation therefore active . 3 . Has systemic condition opinion investigator may affect study outcome variable ; 4 . Is use systemic topical medication opinion investigator may affect study outcome variable ; 5 . Has know sensitivity diagnostic pharmaceutical use study ; 6 . Is pregnant , lactate plan pregnancy time enrollment , determine verbally ; 7 . Is aphakic ; 8 . Has undergone refractive error surgery ; 9 . Has take part another ( pharmaceutical ) research study within last 30 day ; 10 . Has wear contact lens within past 5 year ; 11 . Is currently use use omega 3 supplement past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>